PPH - Market Vectors Pharmaceutical ETF

Description: The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

Last Updated:

PPH - Profile


Summary Data for PPH

52 Week Lo: $45.49 52 Week Hi: $62.89
AUM: $323.1 M Shares: 5.2 M
Avg. Volume (1 month) 92,670 Avg. Volume (3 month) 100,626
Filings Data as of:

PPH - Holdings

Top Ten Holdings

  1. Johnson & Johnson JNJ: 10.82%
  2. Novartis AG ADR NVS: 10.06%
  3. Pfizer Inc PFE: 7.30%
  4. Merck & Co Inc MRK: 5.69%
  5. Sanofi ADR SNY: 5.24%
  6. Novo Nordisk A/S ADR NVO: 5.06%
  7. GlaxoSmithKline PLC ADR GSK: 4.79%
  8. Eli Lilly and Co LLY: 4.58%
  9. AbbVie Inc ABBV: 4.56%
  10. Allergan Inc AGN: 4.54%
%Assets in Top 10: 62.65%
Total Holdings: 27.0

PPH Asset Allocation


Asset Percentage
U.S. Stocks 53.55%
International Stocks 46.32%
U.S. Bonds 0.0%
International Bonds 0.0%
Preferred Stock 0.0%
Convertibles 0.0%
Cash 0.12%
Other 0.0%

PPH Sector Breakdown


Sector Percentage
Health Care 99.88%
Financial Services 0.0%
Communication Services 0.0%
Consumer Defensive 0.0%
Real Estate 0.0%
Industrials 0.0%
Consumer Cyclical 0.0%
Basic Materials 0.0%
Energy 0.0%
Technology 0.0%
Utilities 0.0%

PPH Market Cap Breakdown


Market Cap Percentage
Giant 78.69%
Large 17.26%
Medium 2.36%
Small 0.0%
Micro 0.0%

PPH Region Breakdown


Region Percentage
U.S. 53.55%
Europe 23.63%
Middle East 4.42%
Canada 3.16%
Asia (Developed) 0.0%
Africa 0.0%
Australia 0.0%
Latin America 0.0%
Japan 0.0%
Asia (Emerging) 0.0%
Region Percentage
Developed 99.88%
Emerging 0.0%

PPH Country Breakdown


Country Percentage
United States 53.55%
United Kingdom 13.28%
Switzerland 10.06%
France 5.24%
Ireland 5.11%
Denmark 5.06%
Israel 4.42%
Canada 3.16%
Other 0.12%
© 2014 Morningstar Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

PPH - Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Download the PDF
It appears you don't have Adobe Reader or PDF support in this web browser. Click here to download the PDF

Having trouble viewing?
Visit Adobe.com to install Adobe Acrobat Viewer.

PPH - Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of PPH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

PPH - Fundamentals

PPH Performance

1 Week Return: -2.20%
2 Week Return: -1.05%
4 Week Return: -3.26%
13 Week Return: 0.71%
26 Week Return: 12.73%
YTD Return: 15.34%
1 Year Return: 29.18%
3 Year Return: 87.08%
5 Year Return: 105.33%

PPH Expenses & Fees

PPH Valuation

P/E Ratio: 18.22
Beta: -1.11
20 Day Moving Average: $61.76
60 Day Moving Average: $60.70

PPH Dividend

Annual Dividend Rate: $1.03
Dividend Date: 2014-07-01
Dividend: $0.26
Annual Dividend Yield %: 1.67%

PPH Volatility

5 Day Volatility: 15.64%
20 Day Volatility: 10.37%
50 Day Volatility: 9.36%
200 Day Volatility: 12.41%
Standard Deviation: 5.33%

PPH - Technicals

PPH Technicals

20 Day MA: $61.76
60 Day MA: $60.70
MACD 15 Period: -1.11
MACD 100 Period: 1.05
Williams % Range 10 Day: 100.00
Williams % Range 20 Day: 100.00
RSI 10 Day: 34
RSI 20 Day: 45
RSI 30 Day: 49
Ultimate Oscillator: 39

PPH Bollinger Bands

Lower Bollinger (10 Day): $60.96
Upper Bollinger (10 Day): $62.40
Lower Bollinger (20 Day): $61.02
Upper Bollinger (20 Day): $62.52
Lower Bollinger (30 Day): $60.91
Upper Bollinger (30 Day): $62.59

PPH Support & Resistance

Support Level 1: $60.31
Support Level 2: $60.02
Resistance Level 1: $61.16
Resistance Level 2: $61.72

PPH Stochastic

Stochastic Oscillator %D (1 Day): 37.21
Stochastic Oscillator %D (5 Day): 25.93
Stochastic Oscillator %K (1 Day): 48.08
Stochastic Oscillator %K (5 Day): 37.84

PPH Volatility

5 Day Volatility: 15.64%
20 Day Volatility: 10.37%
50 Day Volatility: 9.36%
200 Day Volatility: 12.41%
Standard Deviation: 5.33%

PPH - ETFdb Realtime Rating & Analyst Report

PPH is a passive ETF that seeks to replicate Market Vectors US Listed Pharmaceutical 25 Index. The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

ETFdb Category Expense Ratio Inception Date Issuer Structure YTD Return *
Health & Biotech Equities 0.35 2011-12-20 Van Eck ETF +15.34%

PPH Realtime Rating: By Metric

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A-
Expenses A-
Performance ETFdb Pro Members Only
Volatility ETFdb Pro Members Only
Dividend ETFdb Pro Members Only
Concentration ETFdb Pro Members Only

The first adjacent table gives investors an individual Realtime Rating for PPH on several different metrics, including liquidity, expenses, performance, volatility, dividend, and concentration of holdings. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities ETFdb Category with the highest Metric Realtime Rating for each individual field.

PPH Realtime Rating: Overall

ETFdb Rating Type Overall Rating A+ Overall Rated ETF
Realtime Rating (Overall) ETFdb Pro Members Only ETFdb Pro Members Only

The second table shows the overall Realtime Rating for PPH, as well as the A+ Overall Rated ETF in PPH's Category. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

ETFdb Analyst Report for PPH

This ETF is one of several options for achieving exposure to the pharma industry, a corner of the health care market that is capable of delivering big returns but that also comes with some unique risk factors. Given this investment objective, PPH is probably more useful for those looking to achie...

Pro Membership Required to Continue Reading ETFdb Pro Members Only

To view the entire ETFdb Realtime Rating, you must be an ETFdb Pro member. To see all that is included in the ETFdb Realtime Rating, see the free previews of ten of the most popular ETFs: SPY, GLD, VWO, EFA, EEM, IVV, QQQ, TIP, VTI, LQD . Please login or begin your 14-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:

  • Register on ETFdb Get valuable insight from our analysts in the ETFdb Category reports, with in-depth breakdown every ETF niche, large or small.
  • Get portfolio guidance on nearly every possible investor scenario and include detailed information on risk profiles, asset correlation, portfolio management, and more.
  • Get access to our premium monthly newsletter ETF Edge.
  • Gain access to premium research reports covering popular sectors of the ETF industry.
  • Read in-depth monthly Q&A's with our Senior Analyst Michael Johnston.
  • Use the ETFdb Pro Screener to screen ETFs according to your own customized parameters, then download the results in Microsoft Excel format.
  • Get 100% access to the ETF Head-To-Head Comparison Tool, a resource that shows how more than 1,100 ETFs stack up against the competition in terms of performance, holdings, and technical strength.

Begin Your Free 14-Day Trial Now - or - Read more about ETFdb Pro

Latest PPH News Stories

Search ETF Database

Enter a ticker symbol or keyword: